Prospective buyers view the backyard of a home during an open house in Seattle, Washington, US, on Sunday, Jan. 18, 2026. David Ryder | Bloomberg | Getty Images Mortgage rates finally ticked a tiny bit lower last week, but not enough to help the ailing mortgage market. Economic uncertainty, fueled by the Iran war, is keeping rates elevated and homebuyers on the fence. As a result, total mortgage application volume fell 0.8% last week compared with the previous week, according to the Mortgage Bankers Association's seasonally adjusted index. The average contract interest rate for 30-year fixed-rate mortgages with conforming loan balances, $832,750 or less, decreased to 6.51% from 6.57%, with points decreasing to 0.61 from 0.65, including the origination fee, for loans with a 20% down payment. Applications for a mortgage to purchase a home rose 1% for the week but were 7% lower than the same week one year ago. That was the first year-over-year decline since January 2025. "However, certain loan types and geographic segments are faring better than others because of lower rates on ARM and FHA loans as well as growing housing inventory in some local markets," said Joel Kan, an MBA economist in a release. "Applications for FHA purchase applications were up 5 percent over the week, supported by the FHA mortgage rate being about 30 basis points lower than the conventional mortgage rate." Get Property Play directly to your inbox CNBC's Property Play with Diana Olick covers new and evolving opportunities for the real estate investor, delivered weekly to your inbox. Subscribe here to get access today . Applications to refinance a home loan dropped 3% for the week and were 4% lower than the same week one year ago. That was also the first year-over-year decline for refinances since January 2025. "Many potential refinance borrowers have been frozen out by the sharp increase over the past month. The pace of refinance applications was at its lowest level since December 2025," said Ka...

BRAMPTON, Ontario, April 08, 2026 (GLOBE NEWSWIRE) -- Loblaw Companies Limited (TSX: L) announced today that it will release its 2026 first quarter results on May 6 th , 2026, at approximately 6:30 a.m. (ET). The release will be followed by a conference call at 10:00 a.m. (ET), as well as an audio webcast.

BRAMPTON, Ontario, 08 avr. 2026 (GLOBE NEWSWIRE) -- Les Compagnies Loblaw Limitée (TSX : L) a annoncé aujourd’hui qu’elle publiera ses résultats du premier trimestre de 2026 le 6 mai 2026, à environ 6 h 30 (HAE). La publication sera suivie d’une téléconférence à 10 h (HAE), en plus d’une webémission.

Continuous glucose monitors — also referred to as glucose biosensors — aren’t just for diabetics anymore. Daily life is different when you're tracking glucose. A little over a year ago, I was on my way to a conference. My bags were packed, the Uber was on its way, but there was one last thing to do before I could head to the airport. Tearing open a small isopropyl alcohol wipe, I cleaned the skin on the back of my arm. After that, I applied a small applicator to the clean skin, doing my best to ignore the visible needle inside. I squeezed my eyes shut and pressed a button. It made a ka-thunk. I repeated the process on the other arm. In my right arm, I now had a Dexcom Stelo. In the left, an Abbott Lingo. Both were over-the-counter continuous g … Read the full story at The Verge.

MONTRÉAL, April 08, 2026 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“ OR Royalties ” or the “ Company ”) (OR: TSX & NYSE) is pleased to announce its first quarter 2026 preliminary deliveries, revenues and cash margin, as well as to provide an update on its cash and debt positions as at March 31 st , 2026. All monetary amounts included in this report are expressed in United States dollars, unless otherwise noted.

MONTRÉAL, 08 avr. 2026 (GLOBE NEWSWIRE) -- Redevances OR Inc. (« Redevances OR » ou la « Société ») (TSX et NYSE : OR) a le plaisir d’annoncer ses livraisons, ses produits et sa marge monétaire préliminaires pour le premier trimestre de 2026, ainsi que sur sa position de trésorerie et sa dette au 31 mars 2026. Tous les montants inclus dans ce communiqué sont présentés en dollars américains, sauf indication contraire.

Sunrise Technologies, a global Microsoft AI Business Applications and Cloud solutions provider, announced today that Franklin Sports, a leading sporting goods and equipment brand, has chosen Microsoft Dynamics 365 Finance and Supply Chain Management as its new enterprise resource planning (ERP) platform. The company will partner with Sunrise Technologies to replace multiple legacy applications and unify its operations with Microsoft's scalable, cloud-based solution.

ZINFI Technologies, Inc., the #1 user and analyst-rated channel management and partner ecosystem management platform for technology and manufacturing companies and industry leader in Unified Partner Management (UPM), today announced that its platform is now available for transaction on the Microsoft Commercial Marketplace. The listing reflects direct demand from Fortune 100 customers and debuts with an exceptional 4.9 out of 5.0 star rating based on 667+ verified reviews — making ZINFI one of th

当地时间4月8日，联合国巴勒斯坦被占领土（包括东耶路撒冷）和以色列问题独立国际调查委员会警告称，美伊冲突掩盖了巴勒斯坦被占领土上激增的侵犯人权事件。该委员会称，自2月28日以来，加沙已有至少200名巴勒斯坦人死于以军袭击，医疗后送几乎完全暂停。包括东耶路撒冷在内的约旦河西岸有22人被以色列安全部队或定居者杀害。此外，委员会还谴责以色列议会通过针对巴勒斯坦人的死刑法案，并重申以军在加沙的种族灭绝行为仍在继续。委员会呼吁各方立即停止暴力，保护平民，遵守国际法。（央视新闻）

格隆汇4月8日｜欧盟委员会发言人：这场能源危机不会是短期的。

Is the AI Gold Rush Over? Costco and Walmart Just Delivered a Sobering $163 Billion Warning to Shareholders of Nvidia, Palantir, and Other Red-Hot AI Stocks. The Motley Fool

Turkey is working on plans to expand some of the business incentives offered at the Istanbul Financial Center to foreign companies across the country, part of a push to attract multinational firms and position itself as a regional business hub. The Treasury and Finance Ministry is preparing legislation around some of the perks, which are currently limited to firms operating inside Turkey’s nascent flagship financial center, according to people familiar with the matter. The draft is expected to be submitted to parliament in the coming weeks, the people said, asking not to be identified because the discussions are private. The ministry confirmed that preparations are underway but declined to provide details. Turkish officials believe the war between Iran and the US-Israeli alliance could create an opening to attract foreign companies that had previously prioritized regional hubs such as Dubai in the United Arab Emirates, according to the people. While Gulf Arab states got caught in the crosshairs of Iran’s retaliatory strikes on neighboring countries, Turkey’s commercial hub, Istanbul, has so far avoided direct fighting. One of the key measures under consideration would extend nationwide a tax break allowing companies based at the Istanbul Financial Center to deduct 50% of the income they earn from selling — or mediating the sale of — goods sourced abroad without bringing those goods into Turkey, the people said. The plans are not final and may be revised or withdrawn during the legislative process. The Istanbul Financial Center launched in 2023 with hopes of helping turn the city into a global finance hub. Despite hosting key domestic institutions like the central bank and major state-owned lenders, the complex opened partly empty and has struggled to attract foreign companies. Unlike the Gulf, where deep-pocketed sovereign wealth funds generate steady deal flow for global investors and hedge funds, Turkey — a nation of about 90 million people — leans on the scale of...

佛慈制药公告，2025年营业收入9.16亿元，同比下降6.60%。净利润4920.72万元，同比下降18.08%。拟向全体股东每10股派发现金红利0.2元（含税）。

Cameron Turtle, the chief executive officer of Spyre Therapeutics (NASDAQ:SYRE) , reported the direct sale of 15,000 shares of common stock for approximately $740K on April 1, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($49.33); post-transaction value based on April 1, 2026 market close. Spyre Therapeutics is a biotechnology company focused on advancing innovative antibody therapeutics for inflammatory bowel disease. With a market capitalization of $4 billion, Spyre Therapeutics focuses on developing biologic therapies for inflammatory bowel disease. Continue reading

(RTTNews) - Nurix Therapeutics, Inc. (NRIX) reported a first quarter net loss of $87.2 million or $0.79 per share compared with a net loss of $56.4 million or $0.67 per share, prior year. Revenue was $6.3 million compared with $18.5 million, a year ago. The company said revenue f

Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha More on Delta Air Lines Delta Air Lines: Why It Is A Relative Winner (Rating Upgrade) Delta Air Lines Will Potentially Lead In This Year Of Chaos Delta Air Q1 Earnings Preview: A High Bar To Fly Over, Shares Fairly Valued Delta leads the airline sector higher after earnings, oil price decline Delta Air Lines Non-GAAP EPS of $0.64 beats by $0.07, revenue of $15.85B beats by $1.03B

伊朗伊斯兰革命卫队公共关系部今天发布声明称，在代号为“真实承诺4”的第100波行动中，空天部队对敌方25个战略目标发动猛烈攻击，其中包括13个与美国和以色列相关的能源综合体及输油管道、10个军事、安全和后勤目标，以及敌方行进路线上的若干技术与基础设施目标，给予敌人沉重打击。 (CCTV国际时讯)

Investing.com -- Alibaba and China Telecom announced Tuesday the launch of a data center in southern China powered by Alibaba's self-developed Zhenwu AI semiconductors.

imagean/iStock Unreleased via Getty Images Introduction Valaris Limited ( VAL ), the offshore driller, appears to be in a transition year. After a phenomenal 144.5% rally over the last year, partly driven by the Transocean Ltd. ( RIG ) merger news , multiples currently look high for a cyclical name. However, the current valuation appears fair for a company in transition. For one thing, they might reflect the company’s contribution to the combined entity’s pro forma earnings base. More importantly, they reflect idle rigs, legacy contracts, and a temporary ‘whitespace’ period rather than the economics of recently signed contracts, as these new contracts are being signed at considerably higher day rates than the legacy contracts. The question is whether the market is evaluating the stock based on current trough earnings or the contract reality with higher utilization and day rates. Offshore Economics and Why Valaris Matters to the Combined Company Offshore development is driven by multi-year contracts and reserve replacement, not day-to-day oil volatility. As such, management’s comments that 70% of new deepwater spending sanctioned over the next three years break even at $50 per barrel mean Valaris does not even need oil at triple digits to be significantly profitable. These projects are concentrated in core deepwater basins such as Brazil and Guyana, where high-quality reservoirs and established infrastructure support durable offshore activity. The merger details make clear that Valaris is not just being bought for scale. It adds a modern fleet, especially jackups and high-spec drillships, broadens geographic reach, and contributes to a combined backlog of about $10 billion. Within Valaris itself, drillships account for about $3.0 billion of backlog versus about $1.1 billion for jackups, and drillship average day rates are roughly $416k in 2026 and $433k in 2027, far above jackup levels. The combination of Valaris’ jackup stability and drillship earnings leverage give...

designer491 Insmed Incorporated ( INSM ) has decided to halt an R&D program for its lung disorder therapy, brensocatib, following a mid-stage trial failure for the candidate against hidradenitis suppurativa, a skin disorder. Its Phase 2b CEDAR study, designed to evaluate brensocatib in adults with moderate to severe HS, did not meet primary or secondary efficacy endpoints, the Bridgewater, New Jersey-based biotech announced late Tuesday. While both 10 mg and 40 mg dose levels failed to meet the key goals, patients tolerated the experimental therapy well, with no new safety signals even for the highest dose tested so far, according to the company. "While we are disappointed in the results, we hope that insights gained from this study will contribute to the broader scientific understanding of HS,” Insmed’s medical chief, Martina Flammer, remarked. In 2025, the U.S. and Europe approved brensocatib as an oral, once-daily treatment marketed as Brinsupri for non- cystic fibrosis bronchiectasis. More on Insmed Insmed: The Pipeline Is Catching Up To The Valuation Insmed Incorporated (INSM) Shareholder/Analyst Call - Slideshow Insmed: "Strong Buy" As Possible Label Expansion For ARIKAYCE Bodes Well Nasdaq rebounds to end flat as chip, AI-related stocks recover after Trump's speech Top Nasdaq movers this week as tech stocks continue to drag down the index

真主党呼吁民众在官方宣布停火之前，不要返回受袭地区，如黎巴嫩南部和贝鲁特郊区。 责任编辑：江学思

Morning Bid: Big relief rally, for now Reuters

多家航运机构8日表示，美国和伊朗宣布达成为期两周的停火后，霍尔木兹海峡已有船舶通行。据国际货运信息平台海上交通网站消息，一艘希腊籍散货船和一艘悬挂利比里亚国旗的船只已在宣布停火后通过霍尔木兹海峡。(新华社)

Resident doctors in England – the new name for junior doctors – are taking part in their 15th walkout in a long-running pay dispute.

格隆汇4月8日｜据国际文传电讯社，俄罗斯外长拉夫罗夫将于4月17日至18日访问土耳其。

Kwang Mo Koo, Chairman and CEO of LG Corp., visited Silicon Valley—the global epicenter of AI innovation—to clarify LG's direction for AI commercialization and accelerate execution across its business portfolio.

LG Chairman Kwang Mo Koo Visits Silicon Valley to Accelerate AI Transformation and Physical AI Strategy Taiwan News

Douglas Rissing Delta Air Lines ( DAL ) traded higher in premarket action after reporting first-quarter results. Revenue was up 12.9% year over year to $15.9B to top the consensus estimate by $1.0B. The company saw healthy unit revenue improvement across all geographies, with positive inflection in main cabin growth. Total revenue per available seat mile was up 12% to $0.2292, while total cost per available seat mile rose 13% to $0.2220. "Demand remains strong, and we are taking actions to protect our margins and cash flow. This includes meaningfully reducing capacity growth, with a downward bias until the fuel environment improves, and moving quickly to recapture higher fuel costs," highlighted CEO Ed Bastian. Delta ( DAL ) said its fuel bill will be $2B higher this quarter because of the spike in fuel costs. That is despite benefiting from its Trainer refinery. The carrier guided for low-teens revenue growth for the second quarter on flat capacity growth. The airline sector shot up in general on Wednesday after the U.S. and Iran agreed to a two-week, Pakistan-brokered ceasefire after days of escalating conflict and a Trump deadline. The deal pauses U.S. and Israeli strikes on Iran while talks continue, and it is tied to Iran ensuring safe, immediate reopening of the Strait of Hormuz. Notably, both sides are using the truce to negotiate a broader peace framework. Airline stock reactions premarket: American Airlines ( AAL ) +9.4%, Southwest Airlines ( LUV ) +9.6, United Airlines ( UAL ) +11.5, JetBlue Airways ( JBLU ) +7.7%, Alaska Air Group ( ALK ) +8.4%, Allegiant Travel ( ALGT ) +11.4, Spirit Aviation ( FLYYQ ), SkyWest ( SKYW ), Sun Country Airlines ( SNCY ) +5.5%, Republic Airways ( RJET ) +3.3%, and Frontier Group ( ULCC ) +8.9%. More on the airline sector Delta Air Lines: Why It Is A Relative Winner (Rating Upgrade) Delta Air Lines Will Potentially Lead In This Year Of Chaos Delta Air Q1 Earnings Preview: A High Bar To Fly Over, Shares Fairly Valued Delta Air...

Maksim Safaniuk/iStock via Getty Images For most of the past seven years, Energy Transfer LP ( ET ) has traded at a discount to Enterprise Products Partners L.P. ( EPD ). For most of that time, I have believed EPD to be the better-run company and the less risky investment. Much of that view had to do with some questionable M&A moves by the ET Chairman, Kelcy Warren; the more complicated structure of ET, including partial ownership of Sunoco LP ( SUN ) and USA Compression Partners, LP ( USAC ); and higher leverage at ET. In fact, I believe until about mid-2021, those issues left me neutral on ET and a buyer of EPD. Several things changed my views on ET. Most importantly, at the beginning of 2021, founder and Chairman Kelcy Warren stepped down as CEO and was replaced by the long-time COO and long-time CFO, who became co-CEOs. From the beginning, those two preached better integration of past acquisitions and lower leverage. While I am certain Warren still holds enormous sway over decisions at the company, there are two men with the CEO title, and their more deliberate and more conservative management has become apparent in the results. The performance has been good enough that I no longer think the valuation differential (image below) makes sense. EV/EBITDA Valuation Differential between EPD and ET (Bloomberg) Before anyone jumps down my throat, I am still very bullish on EPD and by no means intend to denigrate that company. I absolutely love those assets, that management team, and the controlling Duncan family. They have expanded with incredible discipline and achieved 12% ROIC over the past 10 years while managing the balance sheet to an A- credit rating. They have been far less aggressive with acquisitions, preferring organic growth, which I believe means better returns and less operational risk. With leverage just above 3x and a dialed-back capital expenditure budget for 2026 ($2.7 billion midpoint), the company is pivoting to returning cash to unitholders more agg...

亚马逊美股盘前涨超4%，现报222.45美元。